Fingerprint
Dive into the research topics of 'Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion. Six-Month Primary End Point Results of a Phase III Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion. Six-Month Primary End Point Results of a Phase III Study
Peter A. Campochiaro, Jeffrey S. Heier, Leonard Feiner, Sarah Gray, Namrata Saroj, Amy Chen Rundle, Wendy Yee Murahashi, Roman G. Rubio
Research output: Contribution to journal › Article › peer-review
642
Scopus
citations